Apparently, while reducing obesity might reduce health system costs in the short term, people will live longer, which means higher costs in the long term because they will be, well, alive.
If this is the mindset, at what point does the question become why fund anything?
December 9, 2024 Latest NewsBioPharmaCommentLatest Video
New Stories
-
QIMR Berghofer says cell therapy saving lives of immunocompromised patients
December 11, 2024 - - Australian Biotech -
Welcome and encourage these workarounds because they expose the failing institution
December 11, 2024 - - Latest News -
FivepHusion secures ResectAssist platform technology for the localised delivery of cancer drugs
December 11, 2024 - - Latest News -
Budget update will reveal spending and revenue changes, including for the PBS
December 10, 2024 - - Latest News -
Pharmac seeks feedback on funding medicines for liver and ovarian cancer
December 10, 2024 - - Latest News -
Potential Australian developed treatment for MND shows positive early trial results
December 9, 2024 - - Australian Biotech -
TGA approves UCB therapy for the treatment of Dravet syndrome
December 9, 2024 - - Latest News